Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$874
|
$815B |
17.3x |
47.2x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$202
|
$418B |
7.4x |
16.9x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$162
|
$403B |
4.5x |
12.8x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 630
|
$401B |
9.6x |
19.6x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 301
|
$293B |
4.3x |
11.2x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£116
|
$251B |
4.5x |
13.5x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$89
|
$250B |
3.9x |
9.3x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 98
|
$232B |
4.6x |
11.1x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$303
|
$211B |
6.3x |
10.6x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$206B |
3.2x |
8.5x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$110
|
$155B |
5.4x |
13.6x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$56
|
$154B |
3.2x |
19.6x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€104
|
$146B |
3.1x |
10.8x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$484
|
$120B |
10.8x |
75.8x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$90.8B |
2.3x |
6.5x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7685
|
$77.0B |
9.9x |
20.2x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$160
|
$76.6B |
8.3x |
19.4x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4218
|
$72.7B |
2.4x |
8.9x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$700
|
$70.3B |
4.9x |
12.7x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€136
|
$69.7B |
3.1x |
11.0x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€22
|
$55.8B |
1.2x |
5.3x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$54.4B |
3.8x |
15.4x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1644
|
$43.3B |
7.2x |
25.2x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 48
|
$39.1B |
10.4x |
42.4x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3429
|
$38.0B |
3.2x |
17.2x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€616
|
$35.9B |
15.3x |
374.1x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 62
|
$34.8B |
2.1x |
7.1x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€36
|
$32.2B |
1.4x |
8.7x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$251
|
$31.0B |
13.3x |
1401.2x |
BeiGene
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 165
|
$27.9B |
7.2x |
-76.6x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$27.4B |
1.9x |
5.9x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$141
|
$24.8B |
2.6x |
7.5x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 7194
|
$23.8B |
1.5x |
7.2x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$23.1B |
2.4x |
6.9x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1466
|
$22.0B |
1.8x |
8.9x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 42
|
$19.9B |
1.9x |
9.5x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5757
|
$17.2B |
16.3x |
52.4x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 205
|
$16.7B |
10.7x |
31.6x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$15.9B |
N/A |
-69.8x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€8
|
$14.7B |
2.0x |
8.0x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$81
|
$14.4B |
37.9x |
-16.5x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$361
|
$13.2B |
4.5x |
8.6x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€55
|
$13.2B |
5.3x |
14.4x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1474
|
$12.8B |
4.0x |
15.7x |
Intra-Cellular Therapies
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$129
|
$12.7B |
17.7x |
-143.5x |
Biomarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$68
|
$12.5B |
4.3x |
19.0x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3039
|
$12.0B |
9.1x |
28.1x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$15
|
$12.0B |
1.9x |
6.1x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 20
|
$11.9B |
7.1x |
20.1x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$72
|
$11.8B |
2.8x |
39.8x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$136
|
$11.8B |
2.9x |
6.4x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$120
|
$11.6B |
4.2x |
-10.1x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 312
|
$11.5B |
4.6x |
12.8x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$121
|
$11.4B |
4.8x |
17.2x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1583
|
$11.2B |
3.6x |
11.0x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 23
|
$11.2B |
1.9x |
13.1x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 209
|
$11.1B |
14.7x |
22.9x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1152
|
$11.0B |
3.0x |
10.9x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2327
|
$10.6B |
7.6x |
29.1x |
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$106
|
$10.3B |
5.1x |
19.5x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1906
|
$10.0B |
3.9x |
17.1x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 885
|
$9.9B |
3.8x |
13.1x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€148
|
$9.6B |
N/A |
N/A |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$9.4B |
4.3x |
13.9x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$11
|
$9.3B |
2.1x |
10.3x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2257
|
$8.9B |
3.0x |
7.3x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€109
|
$8.7B |
2.4x |
6.5x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 35
|
$8.2B |
1.4x |
11.9x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$8.1B |
36.6x |
-15.0x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 42
|
$8.0B |
6.7x |
-176.6x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$58
|
$8.0B |
7.7x |
12.3x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 69
|
$8.0B |
21.9x |
-377.3x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€52
|
$7.7B |
4.8x |
16.6x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1115
|
$7.6B |
2.1x |
9.9x |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4279
|
$7.5B |
1.5x |
11.8x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$36
|
$7.4B |
2.4x |
-2.0x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 3
|
$7.3B |
1.8x |
6.9x |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£23
|
$7.3B |
2.4x |
8.9x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 38
|
$7.0B |
N/A |
N/A |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 28944
|
$6.9B |
9.4x |
36.4x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$25
|
$6.7B |
1.5x |
9.5x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$138
|
$6.6B |
15.7x |
-27.2x |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 42
|
$6.5B |
1.7x |
9.5x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$336
|
$6.5B |
28.8x |
-12.3x |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$40
|
$6.4B |
9.5x |
-25.8x |
Telix Pharmaceuticals
|
Australia |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
AUD 30
|
$6.4B |
11.8x |
82.1x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$6.4B |
0.2x |
2.9x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$63
|
$6.3B |
8.8x |
37.0x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 120524
|
$6.3B |
4.3x |
71.1x |
SK Biopharmaceuticals
|
South Korea |
Drug Development & Therapeutics
|
KRW 115100
|
$6.2B |
15.6x |
70.0x |
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$6.2B |
5584.2x |
-9.1x |
Beijing Tongrentang Co
|
China |
Drug Development & Therapeutics
|
CNY 37
|
$6.0B |
2.3x |
13.0x |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 4601
|
$6.0B |
4.0x |
20.3x |
Zealand Pharma
|
Denmark |
Drug Development & Therapeutics
|
DKK 714
|
$6.0B |
233.9x |
-37.7x |
Kelun
|
China |
Drug Development & Therapeutics,
Medical Supplies
|
CNY 28
|
$5.9B |
1.9x |
8.5x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 5
|
$5.9B |
1.4x |
5.7x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 213
|
$5.8B |
23.2x |
-184.3x |
Blueprint Medicines
|
United States of America |
Drug Development & Therapeutics
|
$92
|
$5.7B |
10.6x |
-32.6x |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$50
|
$5.7B |
607.4x |
-10.5x |
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 640
|
$5.7B |
17.8x |
164.8x |